Industry sessions
Corporate Industry Symposia
Long-term osteoporosis treatment: the personalised approach
Thursday May 6th 2021 – Live Stream 1
| 13:30 – 13:35 CEST | Chair’s welcome | Bente Langdahl (Denmark) |
| 13:35 – 14:00 CEST |
Treating osteoporosis in a pandemic: |
Josep Blanch-Rubió (Spain) |
| 14:00 – 14:25 CEST |
Identification and treatment of osteoporisis based on individual fracture risk |
Felicia Cosman (US) |
| 14:25 – 14:50 CEST |
Sequential treatment – transition from anti-resorptives |
Bente Langdahl (Denmark) |
| 14:50 – 15:00 CEST |
Panel discussion |
All Faculty |
Evaluating the effects of bone forming therapy on bone strength: Current and emerging techniques
Friday May 7th 2021 – Live Stream 1
| 13:30 – 13:35 CEST | Welcome and introduction | Claus-C. Glüer (Germany) |
| 13:35 – 13:50 CEST | The fundamentals of bone strenght: Bone mass and beyond | Kenneth Poole (UK) |
| 13:50- 14:05 CEST | Visualising the impact of bone forming therapy on bone Microachritecture | Klaus Engelke (Germany) |
| 14:05 – 14:15 CEST | How can we maximise the skeletal gains achieved with bone forming therapy? | Nuria Guañabens (Spain) |
| 14:15 – 14:55 CEST | Q&A/Panel discussion | All |
| 14:55 – 15:00 CEST | Conclusion and closing remarkts | Claus-C. Glüer (Germany) |
Corporate Mini Symposia
A spotlight on Heterotopic Ossification (HO): advancing diagnosis and care of patients living with FOP
Thursday May 6th 2021
19:00 – 20:00 CEST – Live Stream 2
| 19:00 – 19:10 CEST | Chairperson’s welcome and introduction | Eric Hesse (Germany) |
| 19:10 – 19:30 CEST |
The epidemiology of genetic forms of HO: a focus on FOP |
Geneviève Baujat (France) |
| 19:30 – 19:50 CEST | Solving the puzzle: the clinical relevance of HO volume | Angela Cheung (Canada) |
| 19:50 – 20:00 CEST | Panel discussion and conclusions | Facilitated by Eric Hesse (Germany) |
Revisiting rodent trabecular bone morphometry:
how to interpret primary and secondary spongiosa and where to analyse?
Friday May 7th 2021 – Live Stream 1
| 19h00 – 19h45 CEST | Revisiting rodent trabecular bone morphometry: How to interpret primary and secondary spongiosa and where to analyse? |
Phil Salmon (Belgium) |
| 19h45 – 20h00 CEST | Panel Discussion |
Inozyme Symposium: From GACI to PXE- The Role of ABCC6 Deficiency: From Bench to Clinic
Monday November 15th 2021
Chair:
Anna Teti – Professor PhD – Full Professor of Histology, University of L’Aquila School of Biotechnology, L’Aquila, Italy
Speakers:
Ludovic Martin MD PhD – Professor Dermatology and venereology CHU Angers, Angers, France
Jouni Uitto MD PhD – Professor and Chair, Department of Dermatology & Cutaneous Biology Thomas Jefferson University, Philadelphia, USA
Objectives of the symposium
- Review the current understanding of ABCC6 Deficiency across the age spectrum
- Importance of PPi- Lesson from pre-clinical studies
- Highlight the upcoming clinical studies
- Patient Presentation and Prognosis Review- Dr Marti
- Mechanism of disease/Role of PPi/ pre-clinical data- Dr Uitto
- Upcoming Clinical Studies- Dr Uitto
Sponsored Coffee Shop
Mechanisms and effects of bone-forming therapy on bone metabolism
Thursday May 6th 2021
Time: 12h00 – 12h30 CEST
Speaker: Peter Pietschmann, Austria
ECTS Barista: Stuart Ralston, UK
Friday May 7th 2021
Time: 11h00 – 11h30 CEST
Speaker:
ECTS Barista:
